The Illinois ILPRO, Explained

The Illinois ILPRO is not an exam. The Illinois Pharmacist Readiness and Orientation Program is how Illinois now satisfies the pharmacy law requirement for a pharmacist license, and the Illinois Pharmacists Association runs it as an online, self-paced continuing-education program. Over ten modules, 2.0 contact hours of ACPE credit, a $125 fee, and one end-of-course assessment you pass at 75 percent. You will not book a seat at a test center or sit in front of a proctor, and nothing you do gets converted into a scaled score.

All of that is recent, and most of what you will find online still describes the arrangement it replaced. On June 1, 2026, Governor JB Pritzker signed HB4154, which IDFPR says replaced the pharmacy jurisprudence examination requirement with the ILPRO. So there is no longer an Illinois pharmacy law exam you are required to sit. IDFPR does also say it will "presently" continue to accept the MPJE as a method of examination for licensure under 68 Ill. Admin. Code 1330.330. That keeps the older route open without making it the requirement.

What is the Illinois ILPRO, exactly?

A course with a test at the end of it, delivered through IPhA's online learning system and completed at whatever pace you set. IDFPR's notice calls it an ACPE-approved Illinois pharmacy law education and assessment program developed by IPhA in cooperation with the Department, and sends applicants to ipha.org/ilpro for the program itself.

Everything IPhA publishes about the mechanics fits in seven rows.

Registration runs through IPhA and asks for your NABP e-Profile ID and details matching your IDFPR application, so the two records line up later.

Two things are missing from that list because nobody publishes them: how many questions the assessment holds, and how long you get to answer them. The course is self-paced, and IPhA publishes no time limit, saying only that individual completion times vary. Not publishing a limit is not the same as declaring there is none, so plan around the modules rather than around a clock. If a site quotes you an ILPRO item count, ask where it came from.

What did HB4154 change, and is the MPJE gone?

The statutory default flipped. Before June 2026 an Illinois applicant satisfied the law requirement by passing an examination; now the requirement is the ILPRO, or, in IDFPR's words, any other such program and assessment or test approved by the Department by rule. The MPJE is one of those approved methods, retained under an existing rule rather than by the new statute.

"Presently, IDFPR will continue to accept the MultiState Pharmacy Jurisprudence Exam (MPJE) as a method of examination for licensure" is not the same sentence as "Illinois accepts either." One route is what the law now asks for; the other survives at the Department's discretion. Nobody outside IDFPR knows how long "presently" runs, and anyone who tells you otherwise is filling in a blank the Department left open.

So the choice in front of you today is between the route Illinois legislated and a route Illinois has kept open at its own discretion. ILPRO or MPJE works through that choice in full, including what each one costs you in time.

The names trip people constantly. The ILPRO is not the Illinois version of the MPJE. A different organization runs it, in a different format, at a different price, under a different part of the law. Treat any source that uses the two names interchangeably as a source that has not read IDFPR's notice.

How do you tell Illinois you are taking the ILPRO?

It depends on which door you came in through, and the two answers are opposites.

If you took the NAPLEX through Continental Testing Services or you are using a NAPLEX score transfer, IDFPR tells you to email CTS at pharmacy@continentaltesting.net with your full name, the last four digits of your SSN, your date of birth, and one dictated sentence. That email is one-way. IDFPR calls it an unresponsive address, and says CTS is only keeping track of the waiver so the exam-licensing process runs smoothly when your NAPLEX scores reach IDFPR. Silence there is normal.

IDFPR dictates the wording: "I would like to waive the IL MPJE exam." The exam being waived is the MPJE, the one you are declining. The ILPRO is not an MPJE. That line is simply the one place an official Illinois document sets those letters beside the state's name, and it seeds a hundred confused forum posts.

Endorsement applicants take the other path. If you have been licensed in another state for more than a year and you applied to IDFPR by endorsement, IDFPR says you do not need to contact CTS. You complete the ILPRO, then allow two to three weeks for IPhA to forward your completion to IDFPR and for IDFPR to update your application record. Build that window in now rather than finding it while a job start date closes in. Illinois pharmacist licensure steps lays out the rest of the sequence.

What is the ILPRO pass rate?

There is not one, and we went looking before saying so. Nothing turned up on IPhA's program page, IDFPR's ILPRO notice, IDFPR's pharmacy and Board pages, IDFPR's most recent annual report, the state's 2019 sunset review of the Pharmacy Practice Act, or five CTS pages including the application instructions. The annual report does not use the words MPJE, NAPLEX or jurisprudence anywhere.

A pass rate is something a testing body computes for a scored exam with a candidate cohort. The ILPRO is a single-attempt continuing-education assessment with a fixed threshold, and no organization owns the job of publishing statistics about it. Nobody is going to start, either, so do not wait for a number. The only official performance figure that exists is the standard itself: one opportunity to score 75 percent or better.

Anyone quoting you an ILPRO pass rate has made it up. The same goes for figures borrowed from NABP's MPJE report, which groups examinees by pharmacy school and graduation year rather than by state, so there is no Illinois jurisdiction row to lift. The ILPRO pass rate sets out every source we checked and what to steer by instead.

Does licensure by endorsement get you out of the ILPRO?

No, and this is the single most reliable misreading in Illinois licensure. Endorsement is the route for a pharmacist already licensed elsewhere, and on the clinical side it is genuinely generous. It is also the one route where IDFPR says you do not need to contact CTS, which reads to a lot of people as one fewer requirement rather than one fewer email. Candidates then stretch that relief one step too far and assume the law requirement travels with them.

It does not. Clinical competence is portable because pharmacology does not change at a state line. Knowledge of Illinois law is not, because Illinois law is the thing being asked about. Twenty years behind a counter in another state is evidence of everything except that.

IDFPR's notice settles it on the current facts: the endorsement route is named explicitly as an ILPRO path, with its own two-to-three-week forwarding window. An incoming pharmacist completes the program like anyone else.

How much preparation does a single attempt need?

More than the 2.0 contact hours suggest. Blame the attempt policy rather than the volume of content. Registration buys one opportunity to score 75 percent or better. What happens after a failure is not published anywhere: no waiting period, no attempt cap, and nothing on whether a second registration is available or what it would cost. IPhA's page stops at "one opportunity," and IDFPR's notice does not address failure at all.

So arrive prepared rather than treating the modules as a formality. The cost of passing is published and the cost of failing is not, and a $125 registration is a poor place to find that out.

The subject matter is Illinois pharmacy law, the same body of rules you will practice under and the same material the MPJE tests if you later license into a state that uses it. Illinois Pharmacy Law: A Jurisprudence and ILPRO Study Guide 2026-2027 covers the federal baseline and the Illinois layer with 150 checkpoint questions and full explanations, which is the same preparation whichever route you take.

IPhA is also direct about the limit of what completion buys you: finishing the ILPRO does not by itself produce a license. It satisfies one requirement among several.

Does the ILPRO travel to another state?

No, and neither would an MPJE pass earned in Illinois. NABP's score transfer mechanism applies only to Uniform MPJE results, and Illinois is not a Uniform MPJE jurisdiction. Every receiving state imposes its own law requirement on an incoming pharmacist regardless, so the ILPRO costs you nothing you would otherwise have had.

There is a live wrinkle for people moving the other way, into Illinois. As of September 2026, two official sources say different things. IDFPR, the regulator that issues the license, says the ILPRO satisfies the jurisprudence requirement and names endorsement as an ILPRO path. NABP's licensure transfer general requirements table carries a footer dated August 26, 2026, after both HB4154 and the ILPRO launch, and still lists Illinois as "Pass the MPJE."

IDFPR issues the license, so IDFPR's requirement is the one that decides what you have to do, and on IDFPR's notice that is the ILPRO. The two documents have not been reconciled. If you are transferring in, keep IDFPR's notice to hand, because somebody in the process will quote the older line at you.

Does Illinois use the Uniform MPJE?

No. As of September 2026, thirteen jurisdictions have adopted NABP's Uniform MPJE and NABP maintains the current list. Illinois does not appear on it and has announced no start date. A state that has just legislated its own in-state program looks less likely to join than it did six months ago.

General guidance written by a candidate in Arizona or Ohio describes an exam that cannot ask about any single state's rules, which is a different problem from the one Illinois sets you. The Uniform MPJE, explained covers what that exam is, and Uniform MPJE or a state MPJE sorts out which applies to a given licensure plan.

What does Illinois ask of you after licensure?

The same legislation added a standing requirement. IDFPR's notice says licensees will have to provide evidence of two hours of continuing education in the subject of pharmacy law every renewal cycle following their first renewal. The law component is no longer a one-time gate you clear and forget.

Check the requirement with IDFPR before you plan a renewal around it, and check the fees with IDFPR and IPhA before you pay anything. Illinois changed this system four months ago and the published guidance is still settling.

FAQ

Is the ILPRO an exam or a continuing-education course?

A continuing-education course. The Illinois Pharmacist Readiness and Orientation Program is ACPE-approved, delivered online by the Illinois Pharmacists Association, self-paced across over ten modules worth 2.0 contact hours, and it ends with one assessment you pass at 75 percent. There is no test center and no proctor.

Who administers the ILPRO?

The Illinois Pharmacists Association, in cooperation with IDFPR. Continental Testing Services does not run the program. Its only ILPRO role is receiving the waiver email that takes examination-route candidates out of the MPJE queue.

Does Illinois still accept the MPJE?

Presently, yes. IDFPR says it will continue to accept the MPJE as a method of examination under 68 Ill. Admin. Code 1330.330, but HB4154 made the ILPRO the statutory requirement, and IDFPR's word "presently" is not a commitment. Check IDFPR's notice before you register for either.

What is the ILPRO pass rate?

Nobody publishes one, and after checking IPhA, IDFPR, the state's annual and sunset reports and CTS, we found no sign one has ever existed. The only official figure is the passing standard: one opportunity to score 75 percent or better.

How much does the ILPRO cost?

$125, paid to IPhA at registration. That is separate from IDFPR's application fee and from anything you pay NABP or CTS on the MPJE route, so confirm the current total with IDFPR before budgeting.

Preparing for the Illinois ILPRO? Illinois Pharmacy Law: A Jurisprudence and ILPRO Study Guide 2026-2027 covers the state and federal material with 150 checkpoint questions, every answer explained. Not sure yet? Try 12 of its questions free and we'll email you the sampler PDF.

Mortar & Law is an independent publisher. MPJE and NABP are trademarks of the National Association of Boards of Pharmacy. CPJE is administered by the California State Board of Pharmacy. Our books are independent study material and are not affiliated with, endorsed by, or sponsored by any of them.

Nothing here is legal advice. Exam and licensure requirements change; verify anything you plan to act on with your state board of pharmacy.